Ethical considerations for clinical trials in inflammatory bowel disease.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4008957)

Published in Gastroenterol Hepatol (N Y) on January 01, 2014

Authors

David T Rubin1, Samuel Becker1, Mark Siegler1

Author Affiliations

1: Dr Rubin is a professor of medicine, codirector of the Inflammatory Bowel Disease Center, and associate section chief for educational programs at the University of Chicago Medicine in Chicago, Illinois. Mr Becker is a student at the University of Chicago, where he is also a microbiology research specialist for the Schneewind/Missiakas Lab. Dr Siegler is the Lindy Bergman Distinguished Service Professor of Medicine and Surgery at the University of Chicago Medicine, founding director of the University of Chicago's MacLean Center for Clinical Medical Ethics, and executive director of its Bucksbaum Institute for Clinical Excellence.

Articles cited by this

The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research. J Am Coll Dent (2014) 22.13

Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42

How to do research fairly in an unjust world. Am J Bioeth (2010) 8.24

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial. Gastroenterology (2003) 3.43

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. Clin Gastroenterol Hepatol (2004) 2.99

Physician utilization disparities between the uninsured and insured. Comparisons of the chronically ill, acutely ill, and well nonelderly populations. JAMA (1993) 1.66

Responsible development and application of surgical innovations: a position statement of the Society of University Surgeons. J Am Coll Surg (2008) 1.55

Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.33

Discharges against medical advice: are race/ethnicity predictors? J Gen Intern Med (2006) 1.21

The desperate case: CARE (costs, applicability, research, ethics) JAMA (1989) 1.02

Preventing antibodies to infliximab in patients with Crohn's disease: optimize not immunize. Gastroenterology (2003) 0.88

The placebo response rate in irritable bowel syndrome and inflammatory bowel disease. Dig Dis (2010) 0.85

What you see is not always what you get: raising the bar on clinical trial methodology in ulcerative colitis. Gastroenterology (2013) 0.84

Outsourcing clinical trials. Nat Rev Gastroenterol Hepatol (2009) 0.84

Hospitalizations for inflammatory bowel disease: profile of the uninsured in the United States. Inflamm Bowel Dis (2009) 0.83

Ethical assessment of clinical asthma trials including children subjects. Pediatrics (2004) 0.80

The ethics of phase I trials of biologic agents. Nat Clin Pract Gastroenterol Hepatol (2008) 0.78

Placebo-controlled clinical trials in gastroenterology. A position paper of the American College of Gastroenterology. Am J Gastroenterol (1984) 0.78